PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'VA Boston Healthcare System, Boston, Massachusetts, United States of America.\', \'Harvard Medical School, Boston, Massachusetts, United States of America.\', \'Evans Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.\', \'Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.\', \'Hospital Epidemiology and Infection Prevention Program, VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.\', \'Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'Section of Infectious Diseases, VA Maine Healthcare System, Togus, Maine, United States of America.\', \'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Providence VA Medical Center, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.\', \'Division of Cardiology, Department of Medicine, Providence VA Medical Center, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.\', \'Infectious Diseases and Rheumatology, White River Jct. VA Medical Center, Hartford, Vermont, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0263591
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 35213547
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35213547>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35213547>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all